Cocrystal Pharma, Inc. - COCP
About Gravity Analytica
Recent News
- 06.05.2025 - 8-K - Current report
- 06.05.2025 - Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
- 06.05.2025 - Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
- 05.29.2025 - 8-K - Current report
- 05.29.2025 - Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
- 05.29.2025 - Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
- 05.28.2025 - Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
- 05.28.2025 - Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
- 05.15.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 05.15.2025 - 8-K - Current report